State Update

National Governors Association Continues its Focus on Reducing Prescription Drug Abuse

(State Policy) Permanent link   All Posts

On July 28, the National Governors Association (NGA) announced the selection of four additional states—Michigan, Minnesota, North Carolina and Wisconsin—to participate in a policy academy regarding the reduction of prescription drug abuse. Earlier this year, NGA announced that the second round of its Prescription Drug Abuse Project will be led by Gov. Brian Sandoval (R-NV) and Gov. Peter Shumlin (D-VT), whose states also will participate.[1

According to the NGA, the abuse of prescription drugs is the fastest growing drug problem in the United States, and is the most common type of drug abuse after marijuana use among teens between the ages of 12 and 17. The selected states will join Nevada and Vermont in developing comprehensive statewide action plans that rely on the use of data and evidence-based strategies for combating this public health and safety crisis. 

Over the course of the next year, selected states will:

  • Participate in two, two-day meetings with other policy academy states;
  • Convene an in-state workshop facilitated by NGA Center for Best Practices staff;
  • Develop a strategic plan for reducing prescription drug abuse;
  • Participate in regular conference calls and other networking activities; and
  • Receive customized ongoing technical assistance from NGA staff and national experts.

“Communities across the country continue to be affected by the abuse of prescription drugs,” said
Gov. Shumlin. “That is why this initiative remains so important for governors. As the leaders of our states, our primary concern is for the health and safety of our citizens.” 


[1] Gov. Robert Bentley (R-AL) and NGA Vice Chair Gov. John Hickenlooper (D-CO) previously led the Prescription Drug Abuse Project. Last winter the NGA released a paper with lessons learned from the first policy academy, Reducing Prescription Drug Abuse: Lessons Learned from an NGA Policy Academy. To learn more, please visit www.nga.org/cms/Rx.